Immunotherapy in ALL: from Bench to Bedside

T- Acute lymphoblastic leukemia: Does our understanding of molecular pathogenesis will impact future treatment?

Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute

New Insights in Role of Cart-T Cell Therapy in Hematological

Genome Editing and Chimeric Antigen Receptors T Cell Therapy

Anthracycline-Related Cardiotoxicity in Patients with Acute Leukemia and Down syndrome: A retrospective study

B-cell-receptor-targeted therapy in CLL

A study on some factors affecting CMV reactivation in allogeneic hematopoietic stem cells transplantation

ALL Management Guideline

The Outcome of Acute Lymphoblastic Leukemia in Infants at National Cancer Institute Egypt: 10 Years Experience